NEW ENGL J MED
| WoS 期刊 JCR 分区 (2026 · JIF) | 综合 SCIE | Q1 | ||
|---|---|---|---|---|
| 学科 | 收录集 | JIF 分区 | JIF 排名 | JIF 百分位 |
| 综合内科 Medicine, General & Internal | SCIE | Q1 | 2/336 |
99.4%
|
| 学科 | 收录集 | JCI 分区 | JCI 排名 | JCI 百分位 |
|---|---|---|---|---|
| 综合内科 Medicine, General & Internal | SCIE | Q1 | 1/276 JCI 25.23 |
100.0%
|
The New England Journal of Medicine (NEJM), abbreviated as NEW ENGL J MED, is a premier peer-reviewed medical journal published by the Massachusetts Medical Society. With an ISSN of 0028-4793 and a remarkable 2026 Impact Factor of 84.5000, it consistently ranks in the top Q1 quartile of the Journal Citation Reports, solidifying its standing as one of the most influential and widely cited journals in clinical medicine and biomedical research. The journal’s scope encompasses all areas of medicine, with a primary focus on original research that directly impacts patient care, including groundbreaking clinical trials, disease mechanisms, diagnostic advances, and therapeutic interventions. NEJM publishes a diverse array of article types, including original research articles, comprehensive review articles, clinical practice guidelines, case reports, editorials, and special reports. Its target audience is broad, ranging from practicing physicians and medical researchers to healthcare policymakers and educators worldwide. Notable features include its rigorous double-blind peer-review process, rapid publication of critical findings, and a strong commitment to open access through the NEJM.org platform, where many articles are freely accessible after a brief embargo period. The journal is also renowned for its distinctive “Images in Clinical Medicine” and “Clinical Problem-Solving” features, which enhance diagnostic reasoning. As a top-tier publication, NEJM sets the global standard for medical evidence, influencing clinical practice and health policy across all specialties.